83 related articles for article (PubMed ID: 25258012)
1. MRP1 and GSTp1 expression in non-small cell lung cancer does not correlate with clinicopathological parameters: A Slovakian population study.
Rybárová S; Hodorová I; Mihalik J; Mirossay L
Acta Histochem; 2014 Oct; 116(8):1390-8. PubMed ID: 25258012
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance-associated protein (MRP1) is overexpressed in DNA aneuploid carcinomatous cells in non-small cell lung cancer (NSCLC).
Doubre H; Césari D; Mairovitz A; Bénac C; Chantot-Bastaraud S; Dagnon K; Antoine M; Danel C; Bernaudin JF; Fleury-Feith J
Int J Cancer; 2005 Feb; 113(4):568-74. PubMed ID: 15472893
[TBL] [Abstract][Full Text] [Related]
3. Prognostic evaluation of CapG, gelsolin, P-gp, GSTP1, and Topo-II proteins in non-small cell lung cancer.
Zhu WY; Hunag YY; Liu XG; He JY; Chen DD; Zeng F; Zhou JH; Zhang YK
Anat Rec (Hoboken); 2012 Feb; 295(2):208-14. PubMed ID: 22190510
[TBL] [Abstract][Full Text] [Related]
4. Integrin-Linked Kinase, Snail and Multidrug Resistance Protein 1: Three concordant players in the progression of non-small cell lung cancer.
Abd El-Rehim DM; Abd-Elghany MI; Nazmy MH
J Egypt Natl Canc Inst; 2015 Sep; 27(3):129-37. PubMed ID: 25964055
[TBL] [Abstract][Full Text] [Related]
5. [Expression of proteins associated with multidrug resistance and resistance to chemotherapy in lung cancer].
Paredes Lario A; Blanco García C; Echenique Elizondo M; Lobo C
Arch Bronconeumol; 2007 Sep; 43(9):479-84. PubMed ID: 17919413
[TBL] [Abstract][Full Text] [Related]
6. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.
Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH
Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522
[TBL] [Abstract][Full Text] [Related]
7. Expression of the multidrug resistance-associated protein 1 (MRP1) and the lung resistance-related protein (LRP) in human lung cancer.
Rybárová S; Hajduková M; Hodorová I; Kocisová M; Böör A; Brabencová E; Kasan P; Biros E; Mojzis J; Mirossay L
Neoplasma; 2004; 51(3):169-74. PubMed ID: 15254668
[TBL] [Abstract][Full Text] [Related]
8. [Multidrug resistance and its relationship with neuroendocrine differentiation in non-small cell lung carcinoma].
Yu SP; Xiong YY; Tian SF
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Mar; 26(3):165-8. PubMed ID: 12816683
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients.
Moureau-Zabotto L; Ricci S; Lefranc JP; Coulet F; Genestie C; Antoine M; Uzan S; Lotz JP; Touboul E; Lacave R
Br J Cancer; 2006 Feb; 94(4):473-80. PubMed ID: 16434992
[TBL] [Abstract][Full Text] [Related]
10. Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane.
Sibhatu MB; Smitherman PK; Townsend AJ; Morrow CS
Carcinogenesis; 2008 Apr; 29(4):807-15. PubMed ID: 18204073
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of the multidrug resistance‑associated protein 1 gene in non‑small cell lung cancer: A systematic review and meta‑analysis.
Hu P; Wong PT; Zhou Q; Sheng L; Niu W; Chen S; Xu M; Lin Y
Oncol Rep; 2018 Nov; 40(5):3078-3091. PubMed ID: 30132569
[TBL] [Abstract][Full Text] [Related]
12. Role of glutathione S-transferase P1-1 in the cellular detoxification of cisplatin.
Peklak-Scott C; Smitherman PK; Townsend AJ; Morrow CS
Mol Cancer Ther; 2008 Oct; 7(10):3247-55. PubMed ID: 18852128
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical evaluation of Pi class glutathione S-transferase expression in invasive breast carcinoma.
Vecanova J; Hodorova I; Mihalik J; Benicky M; Kluchova D; Rybarova S
Bratisl Lek Listy; 2011; 112(2):67-70. PubMed ID: 21456504
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH
Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478
[TBL] [Abstract][Full Text] [Related]
15. The expression of GST isoenzymes and p53 in non-small cell lung cancer.
Oguztüzun S; Aydin M; Demirag F; Yazici U; Ozhavzali M; Kiliç M; Işcan M
Folia Histochem Cytobiol; 2010 Jan; 48(1):122-7. PubMed ID: 20529827
[TBL] [Abstract][Full Text] [Related]
16. Proteome analysis and tissue array for profiling protein markers associated with type B thymoma subclassification.
Sun QL; Fang WT; Feng J; Zhang J; Yang XH; Gu ZT; Zhu L; Sha HF
Chin Med J (Engl); 2012 Aug; 125(16):2811-8. PubMed ID: 22932072
[TBL] [Abstract][Full Text] [Related]
17. Regulation and control of nitric oxide (NO) in macrophages: Protecting the "professional killer cell" from its own cytotoxic arsenal via MRP1 and GSTP1.
Kovacevic Z; Sahni S; Lok H; Davies MJ; Wink DA; Richardson DR
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):995-999. PubMed ID: 28219722
[TBL] [Abstract][Full Text] [Related]
18. Glutathione-S-transferase P1 isoenzyme polymorphisms, platinum-based chemotherapy, and non-small cell lung cancer.
Booton R; Ward T; Heighway J; Ashcroft L; Morris J; Thatcher N
J Thorac Oncol; 2006 Sep; 1(7):679-83. PubMed ID: 17409936
[TBL] [Abstract][Full Text] [Related]
19. A Nitric Oxide Storage and Transport System That Protects Activated Macrophages from Endogenous Nitric Oxide Cytotoxicity.
Lok HC; Sahni S; Jansson PJ; Kovacevic Z; Hawkins CL; Richardson DR
J Biol Chem; 2016 Dec; 291(53):27042-27061. PubMed ID: 27866158
[TBL] [Abstract][Full Text] [Related]
20. Expression of MDR proteins in breast cancer and its correlation with some clinical and pathological parameters.
Rybárová S; Hodorová I; Hajduková M; Schmidtová K; Mojzis J; Kajo K; Kviatkovská Z; Plank L; Benický M; Mirossay A; Biros E; Bobrov N; Wagnerová M; Berc A; Mirossay L
Neoplasma; 2006; 53(2):128-35. PubMed ID: 16575468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
